Product Information

TEMOZOLOMIDE 100 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $4.0674 per EA under NDC 67877053914. Its NADAC has been published 118 times since Aug 21, 2024.

FDA first approved this application on Apr 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TEMOZOLOMIDE 100 MG CAPSULE

Temozolomide
$4.0674per EA

Strength

100 mg/1

NDC

67877053914

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TEMOZOLOMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207658

FDA Approved

4/26/2017

TE Code

AB

On Market Since

4/28/2017

Pharmacological Classes

Alkylating Activity
Alkylating Drug

Price Statistics

The NADAC for TEMOZOLOMIDE 100 MG CAPSULE has been published 118 times since Aug 21, 2024, and over the history we have for it it has declined 54.4%. The table below summarizes its recorded NADAC range and movement.

Current price$4.0674 per EA
All-time high$13.5895 (Feb 12, 2025)
All-time low$4.0674 (Nov 18, 2026)
52-week high$10.3266
52-week low$4.0674
Median price$9.3971
Average price$9.3226
Largest weekly change+34.3% (Oct 23, 2024)
Weeks tracked118
Tracking sinceAug 21, 2024

Price History

1W

-5.1%

1M

-7.0%

3M

-14.6%

6M

-51.5%

1Y

-55.2%

3Y

N/A

5Y

N/A

All

-54.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TEMOZOLOMIDE 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 100 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $4.0674 per EA (NDC 67877053914), effective Nov 18, 2026.

How has the price of TEMOZOLOMIDE 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TEMOZOLOMIDE 100 MG CAPSULE has declined 54.4%. It has been tracked across 118 weekly CMS publications since Aug 21, 2024.

What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 100 MG CAPSULE?

Since Aug 21, 2024, the NADAC for TEMOZOLOMIDE 100 MG CAPSULE has ranged from a low of $4.0674 (Nov 18, 2026) to a high of $13.5895 (Feb 12, 2025), with a median of $9.3971 per EA.

Are there cheaper alternatives to TEMOZOLOMIDE 100 MG CAPSULE?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMOZOLOMIDE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TEMOZOLOMIDE 100 MG CAPSULE?

TEMOZOLOMIDE 100 MG CAPSULE (NDC 67877053914) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.